Corrigendum to: Peroxisome proliferator-activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target (EMBO Mol Med, (2017), 9, (508-530), 10.15252/emmm.201506111)

Oren Pleniceanu, Racheli Shukrun, Dorit Omer, Einav Vax, Itamar Kanter, Klaudyna Dziedzic, Naomi Pode-Shakked, Michal Mark-Daniei, Sara Pri-Chen, Yehudit Gnatek, Hadas Alfandary, Nira Varda-Bloom, Dekel D. Bar-Lev, Naomi Bollag, Rachel Shtainfeld, Leah Armon, Achia Urbach, Tomer Kalisky, Arnon Nagler, Orit Harari-SteinbergJack L. Arbiser, Benjamin Dekel

Research output: Contribution to journal › Comment/debate

4 Scopus citations

Fingerprint

Dive into the research topics of 'Corrigendum to: Peroxisome proliferator-activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target (EMBO Mol Med, (2017), 9, (508-530), 10.15252/emmm.201506111)'. Together they form a unique fingerprint.

Corrigendum to: Peroxisome proliferator-activated receptor gamma (PPARγ) is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target (EMBO Mol Med, (2017), 9, (508-530), 10.15252/emmm.201506111)

Fingerprint

Keyphrases

Medicine and Dentistry

Nursing and Health Professions

Agricultural and Biological Sciences